First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients
Titel:
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients
Auteur:
Salazar, Fernanda Molina, Miguel Angel Sanchez-Ronco, Maria Moran, Teresa Ramirez, Jose Luis Sanchez, Jose Miguel Stahel, Rolf Garrido, Pilar Cobo, Manuel Isla, Dolores Bertran-Alamillo, Jordi Massuti, Bartomeu Cardenal, Felipe Manegold, Christian Lianes, Pilar Trigo, Jose Manuel Sanchez, Jose Javier Taron, Miquel Rosell, Rafael